Alx Oncology Holdings annual debt-to-assets ratio
2019
2021
2022
2023
2024
2025
Alx Oncology Holdings Debt-to-Assets Ratio Growth & History (ALXO)
Alx Oncology Holdings's debt-to-assets ratio was 0.25 for fiscal 2025.
View full Alx Oncology Holdings company overviewAlx Oncology Holdings annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.25 | 0.14 | +117.72% |
| 2024 | 2024-12-31 | 0.11 | 0.04 | +62.05% |
| 2023 | 2023-12-31 | 0.07 | 0.02 | +38.43% |
| 2022 | 2022-12-31 | 0.05 | 0.04 | +614.85% |
| 2021 | 2021-12-31 | 0.01 | — | — |
| 2019 | 2019-12-31 | 0.51 | — | — |
Alx Oncology Holdings quarterly debt-to-assets ratio
Q4.19
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.07 | −0.10 | −59.57% |
| Q1 2026 | 2026-03-31 | 0.07 | −0.06 | −46.66% |
| Q4 2025 | 2025-12-31 | 0.25 | 0.14 | +117.72% |
| Q3 2025 | 2025-09-30 | 0.19 | 0.10 | +101.86% |
| Q2 2025 | 2025-06-30 | 0.17 | 0.09 | +108.53% |
| Q1 2025 | 2025-03-31 | 0.14 | 0.06 | +73.21% |
| Q4 2024 | 2024-12-31 | 0.11 | 0.04 | +62.05% |
| Q3 2024 | 2024-09-30 | 0.09 | 0.03 | +36.89% |
| Q2 2024 | 2024-06-30 | 0.08 | 0.02 | +32.08% |
| Q1 2024 | 2024-03-31 | 0.08 | 0.02 | +42.43% |
| Q4 2023 | 2023-12-31 | 0.07 | 0.02 | +38.43% |
| Q3 2023 | 2023-09-30 | 0.07 | 0.05 | +227.87% |
| Q2 2023 | 2023-06-30 | 0.06 | 0.04 | +211.63% |
| Q1 2023 | 2023-03-31 | 0.06 | 0.04 | +247.46% |
| Q4 2022 | 2022-12-31 | 0.05 | 0.04 | +614.85% |
| Q3 2022 | 2022-09-30 | 0.02 | 0.01 | +185.77% |
| Q2 2022 | 2022-06-30 | 0.02 | 0.01 | +180.00% |
| Q1 2022 | 2022-03-31 | 0.02 | 0.01 | +1202.25% |
| Q4 2021 | 2021-12-31 | 0.01 | — | — |
| Q3 2021 | 2021-09-30 | 0.01 | −0.01 | −66.80% |
| Q2 2021 | 2021-06-30 | 0.01 | −0.05 | −87.09% |
| Q1 2021 | 2021-03-31 | 0.00 | — | — |
| Q3 2020 | 2020-09-30 | 0.02 | — | — |
| Q2 2020 | 2020-06-30 | 0.05 | — | — |
| Q4 2019 | 2019-12-31 | 0.51 | — | — |
Alx Oncology Holdings debt-to-assets ratio trends
Between the periods ended 2019-12-31 and 2025-12-31, Alx Oncology Holdings's debt-to-assets ratio decreased from 0.51 to 0.25, a change of −0.26. The latest reported quarter, Q2 2026, shows 0.07.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alx Oncology Holdings source filings ↗